Published Date: 04 Mar 2023
A new study by Robin von Rotz and his team found that moderate doses of psilocybin for at least two weeks reduced symptoms of depression...
Read Full NewsSwiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin.
Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.
Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.
An observational study suggests that bone mineral density may serve as a marker of systemic health.
Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.
Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.
1.
CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record
2.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
3.
10-year study shows tomosynthesis improves breast cancer detection
4.
Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy
5.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
1.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
2.
Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant
3.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
4.
Cowden Syndrome and Cancer: Understanding the Risk Factors
5.
Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation